(Q37514846)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19516275%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

review article

1 reference

title

Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19516275%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19516275%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Niccolo Bolli

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19516275%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

author name string

A Liso

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19516275%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

M P Martelli

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19516275%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

R Mannucci

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19516275%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

S Pileri

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19516275%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

I Nicoletti

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19516275%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

publication date

11 June 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19516275%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19516275%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19516275%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19516275%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

page(s)

1731-1743

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19516275%20AND%20SRC:MED&resulttype=core&format=json

New insights into the nucleophosmin/nucleoplasmin family of nuclear chaperones

30 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

Characterization of the cDNA encoding human nucleophosmin and studies of its role in normal and abnormal growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

Role of nucleophosmin in embryonic development and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

Translocations and mutations involving the nucleophosmin (NPM1) gene in lymphomas and leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

Silver staining, immunofluorescence, and immunoelectron microscopic localization of nucleolar phosphoproteins B23 and C23

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

Increased expression of a COOH-truncated nucleophosmin resulting from alternative splicing is associated with cellular resistance to ionizing radiation in HeLa cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

Major nucleolar proteins shuttle between nucleus and cytoplasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

Nucleophosmin/B23 is a proliferate shuttle protein associated with nuclear matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

21 January 2018

Nucleophosmin and cancer

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

Temporal and spatial control of nucleophosmin by the Ran-Crm1 complex in centrosome duplication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

Nucleophosmin is essential for ribosomal protein L5 nuclear export

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

Protein sequence requirements for function of the human T-cell leukemia virus type 1 Rex nuclear export signal delineated by a novel in vivo randomization-selection assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

Nuclear transport and cancer: from mechanism to intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

Kinetic and molecular analysis of nuclear export factor CRM1 association with its cargo in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

Physiological importance of RNA and protein mobility in the cell nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

In nucleoli, the steady state of nucleolar proteins is leptomycin B-sensitive

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

NOPdb: Nucleolar Proteome Database--2008 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

Structural Consequences of Nucleophosmin Mutations in Acute Myeloid Leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

The solution structure of ribosomal protein S17E from Methanobacterium thermoautotrophicum: A structural homolog of the FF domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

Tryptophans 286 and 288 in the C-terminal region of protein B23.1 are important for its nucleolar localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

A dose-dependent tug of war involving the NPM1 leukaemic mutant, nucleophosmin, and ARF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

A ribosomal protein L23-nucleophosmin circuit coordinates Mizl function with cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

The natural product avrainvillamide binds to the oncoprotein nucleophosmin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

The structure and functions of NPM1/Nucleophsmin/B23, a multifunctional nucleolar acidic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

The RNA binding activity of a ribosome biogenesis factor, nucleophosmin/B23, is modulated by phosphorylation with a cell cycle-dependent kinase and by association with its subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

Thr199 phosphorylation targets nucleophosmin to nuclear speckles and represses pre-mRNA processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

Nucleolar structure and function are regulated by the deubiquitylating enzyme USP36.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

Sumoylation of nucleophosmin/B23 regulates its subcellular localization, mediating cell proliferation and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

Nucleolus: the fascinating nuclear body

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

Nucleophosmin serves as a rate-limiting nuclear export chaperone for the Mammalian ribosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

Born to be exported: COOH-terminal nuclear export signals of different strength ensure cytoplasmic accumulation of nucleophosmin leukemic mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

In human genome, generation of a nuclear export signal through duplication appears unique to nucleophosmin (NPM1) mutations and is restricted to AML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

Proteins encoded by genes involved in chromosomal alterations in lymphoma and leukemia: clinical value of their detection by immunocytochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

Deregulation of NPM and PLZF in a variant t(5;17) case of acute promyelocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

Npm1 is a haploinsufficient suppressor of myeloid and lymphoid malignancies in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biologic and clinical features

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

Down-regulation of nucleophosmin/B23 during retinoic acid-induced differentiation of human promyelocytic leukemia HL-60 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

Cell line OCI/AML3 bears exon-12 NPM gene mutation-A and cytoplasmic expression of nucleophosmin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

Monitoring minimal residual disease in acute myeloid leukaemia with NPM1 mutations by quantitative PCR: clonal evolution is a limiting factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

Cytoplasmic localization of NPM in myeloid leukemias is dictated by gain-of-function mutations that create a functional nuclear export signal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

NESbase version 1.0: a database of nuclear export signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

Myeloid leukemia-associated nucleophosmin mutants perturb p53-dependent and independent activities of the Arf tumor suppressor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

Delocalization and destabilization of the Arf tumor suppressor by the leukemia-associated NPM mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

Mutated nucleophosmin detects clonal multilineage involvement in acute myeloid leukemia: Impact on WHO classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

The ARF tumour suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

Physical and functional interactions of the Arf tumor suppressor protein with nucleophosmin/B23

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

Divorcing ARF and p53: an unsettled case

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

N-terminal polyubiquitination and degradation of the Arf tumor suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

Nucleophosmin is required for DNA integrity and p19Arf protein stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

Protein degradation and protection against misfolded or damaged proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

Regulation of p14ARF through subnuclear compartmentalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

Nucleophosmin interacts with HEXIM1 and regulates RNA polymerase II transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

Increase sensitivity to chemotherapeutical agents and cytoplasmatic interaction between NPM leukemic mutant and NF-kappaB in AML carrying NPM1 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

Nucleophosmin and its AML-associated mutant regulate c-Myc turnover through Fbw7 gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

The ubiquitin-specific protease USP28 is required for MYC stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

Playing both sides: nucleophosmin between tumor suppression and oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

The leukemia-associated cytoplasmic nucleophosmin mutant is an oncogene with paradoxical functions: Arf inactivation and induction of cellular senescence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

Nucleophosmin (NPM1) mutations in acute myeloid leukemia: an ongoing (cytoplasmic) tale of dueling mutations and duality of molecular genetic testing methodologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

Quantitative assessment of minimal residual disease in acute myeloid leukemia carrying nucleophosmin (NPM1) gene mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

Gene mutations and response to treatment with all-trans retinoic acid in elderly patients with acute myeloid leukemia. Results from the AMLSG Trial AML HD98B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

Leptomycin B inactivates CRM1/exportin 1 by covalent modification at a cysteine residue in the central conserved region

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

Structural basis for leucine-rich nuclear export signal recognition by CRM1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

Phase I trial of elactocin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

Identification of nuclear export inhibitors with potent anticancer activity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

Anticancer peptide CIGB-300 binds to nucleophosmin/B23, impairs its CK2-mediated phosphorylation, and leads to apoptosis through its nucleolar disassembly activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

A phase I trial of the selective oral cyclin-dependent kinase inhibitor seliciclib (CYC202; R-Roscovitine), administered twice daily for 7 days every 21 days

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

TAT-mediated intracellular delivery of NPM-derived peptide induces apoptosis in leukemic cells and suppresses leukemogenesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

Activation of apoptosis in vivo by a hydrocarbon-stapled BH3 helix

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

Nucleophosmin leukaemic mutants contain C-terminus peptides that bind HLA class I molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

Acute myeloid leukemia bearing cytoplasmic nucleophosmin (NPMc+ AML) shows a distinct gene expression profile characterized by up-regulation of genes involved in stem-cell maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

Mapping the functional domains of nucleolar protein B23

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

7 January 2021

Nucleophosmin/B23 (NPM) oligomer is a major and stable entity in HeLa cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

7 January 2021

Identification and characterization of a hexameric form of nucleolar phosphoprotein B23

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

7 January 2021

Effects of interphase and mitotic phosphorylation on the mobility and location of nucleolar protein B23

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

7 January 2021

EXPRESSION OF NUCLEOPHOSMIN/B23 IN NORMAL AND NEOPLASTIC COLORECTAL MUCOSA

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

7 January 2021

Monoclonal antibody to prostate cancer nuclear matrix protein (PRO:4-216) recognizes nucleophosmin/B23

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

7 January 2021

Aberrant subcellular expression of nucleophosmin and NPM-MLF1 fusion protein in acute myeloid leukaemia carrying t(3;5): a comparison with NPMc+ AML

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

7 January 2021

Absence of nucleophosmin 1 (NPM1) gene mutations in common solid cancers

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

7 January 2021

Nucleophosmin mutations in de novo acute myeloid leukemia: the age-dependent incidences and the stability during disease evolution

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

7 January 2021

NPM1 mutations are more stable than FLT3 mutations during the course of disease in patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

7 January 2021

Cytoplasmic mutated nucleophosmin is stable in primary leukemic cells and in a xenotransplant model of NPMc+ acute myeloid leukemia in SCID mice

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

7 January 2021

Cytoplasmic nucleophosmin in myeloid sarcoma occurring 20 years after diagnosis of acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

7 January 2021

Late relapse of acute myeloid leukemia with mutated NPM1 after eight years: evidence of NPM1 mutation stability

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

7 January 2021

Karyotype instability between diagnosis and relapse in 117 patients with acute myeloid leukemia: implications for resistance against therapy

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

7 January 2021

Identification and functional characterization of a cytoplasmic nucleophosmin leukaemic mutant generated by a novel exon-11 NPM1 mutation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

7 January 2021

A new type of NPM1 gene mutation in AML leading to a C-terminal truncated protein

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

7 January 2021

Aberrant cytoplasmic expression of C-terminal-truncated NPM leukaemic mutant is dictated by tryptophans loss and a new NES motif

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

7 January 2021

A comparison of the activity, sequence specificity, and CRM1-dependence of different nuclear export signals

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

7 January 2021

PI3-kinase/Akt is constitutively active in primary acute myeloid leukaemia cells and regulates survival and chemoresistance via NF-kappaB, Mapkinase and p53 pathways

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

7 January 2021

A western blot assay for detecting mutant nucleophosmin (NPM1) proteins in acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

7 January 2021

Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

7 January 2021

Clinical implications of minimal residual disease monitoring by quantitative polymerase chain reaction in acute myeloid leukemia patients bearing nucleophosmin (NPM1) mutations

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

7 January 2021

AML with mutated NPM1 carrying a normal or aberrant karyotype show overlapping biologic, pathologic, immunophenotypic, and prognostic features

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

7 January 2021

Clinical impact of nucleophosmin mutations and Flt3 internal tandem duplications in patients older than 60 yr with acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

7 January 2021

Folding mechanism of the C-terminal domain of nucleophosmin: residual structure in the denatured state and its pathophysiological significance

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

7 January 2021

Reactivation of the p53 tumor suppressor pathway by a stapled p53 peptide

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.124

7 January 2021